SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-000773
Filing Date
2017-02-14
Accepted
2017-02-14 17:23:21
Documents
46
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctxr_10q.htm 10-Q 228565
2 CERTIFICATION ctxr_311.htm EX-31.1 8994
3 CERTIFICATION ctxr_321.htm EX-32.1 3289
  Complete submission text file 0001477932-17-000773.txt   2148982

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ctxr-20161231.xml EX-101.INS 323073
5 XBRL TAXONOMY EXTENSION SCHEMA ctxr-20161231.xsd EX-101.SCH 38641
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctxr-20161231_cal.xml EX-101.CAL 35093
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctxr-20161231_def.xml EX-101.DEF 111171
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctxr-20161231_lab.xml EX-101.LAB 211073
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctxr-20161231_pre.xml EX-101.PRE 176596
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55532 | Film No.: 17610509
SIC: 2834 Pharmaceutical Preparations